A. Chraïbi

Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents

A. Kadiri, A. Chraïbi, F. Marouan et al. · Diabetes Research and Clinical Practice · 1998 · 96 citations

Novopen 3, Diabetes Management, Secondary Failure +9

Is Ramadan Fasting Safe in Type 2 Diabetic Patients in View of the Lack of Significant Effect of Fasting on Clinical and Biochemical Parameters, Blood Pressure, and Glycemic Control?

M. M'guil, Mohammed El Amine Ragala, L. El Guessabi et al. · Clinical and Experimental Hypertension · 2008 · 61 citations

Nutrition, Hypertension, Ramadan Fasting Safe +17

Factors influencing the awareness of diabetic foot risks

F.Z. Lamchahab, N. El Kihal, Ibtissam Khoudri et al. · Annals of Physical and Rehabilitation Medicine · 2011 · 38 citations

Diabetes, Diabetes Mellitus, Diabetic Foot Risks +1

Combined liver and kidney transplantation in patients with chronic nephritis associated with end-stage liver disease

C Hiesse, Didier Samuel, H. Bensadoun et al. · Nephrology Dialysis Transplantation · 1995 · 32 citations

Glomerular Disease, Solid Organ Transplantation, Renal Pathology +23

Argan Oil Exerts an Antiatherogenic Effect by Improving Lipids and Susceptibility of LDL to Oxidation in Type 2 Diabetes Patients

M. M. Ould Mohamedou, K. Zouirech, Mariame El Messal et al. · International Journal of Endocrinology · 2011 · 16 citations · Full text